{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,24]],"date-time":"2025-06-24T04:04:02Z","timestamp":1750737842087,"version":"3.41.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,21]],"date-time":"2025-04-21T00:00:00Z","timestamp":1745193600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,4,21]],"date-time":"2025-04-21T00:00:00Z","timestamp":1745193600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-94942-x","type":"journal-article","created":{"date-parts":[[2025,4,21]],"date-time":"2025-04-21T09:01:21Z","timestamp":1745226081000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Effect of bone marrow blood versus peripheral blood on the hemostatic balance of osteoblasts and endothelial cells"],"prefix":"10.1038","volume":"15","author":[{"given":"Keren","family":"Asayag","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eli","family":"Peled","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yonatan","family":"Crispel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chen","family":"Yanovich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haim","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anat","family":"Keren-Politansky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yona","family":"Nadir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,4,21]]},"reference":[{"issue":"Suppl 3","key":"94942_CR1","first-page":"4","volume":"88","author":"I McCarthy","year":"2006","unstructured":"McCarthy, I. The physiology of bone blood flow: A review. J. Bone Joint Surg. Am. 88(Suppl 3), 4\u20139 (2006).","journal-title":"J. Bone Joint Surg. Am."},{"key":"94942_CR2","doi-asserted-by":"publisher","first-page":"203","DOI":"10.4248\/BR201303001","volume":"1","author":"M Marenzana","year":"2013","unstructured":"Marenzana, M. & Arnett, T. R. The key role of the blood supply to bone. Bone Res. 1, 203\u2013215 (2013).","journal-title":"Bone Res."},{"key":"94942_CR3","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.abb.2010.07.020","volume":"503","author":"A Del Fattore","year":"2010","unstructured":"Del Fattore, A., Capannolo, M. & Rucci, N. Bone and bone marrow: The same organ. Arch. Biochem. Biophys. 503, 28\u201334 (2010).","journal-title":"Arch. Biochem. Biophys."},{"key":"94942_CR4","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1002\/jbmr.3026","volume":"32","author":"K Steer","year":"2017","unstructured":"Steer, K., Stavnichuk, M., Morris, M. & Komarova, S. V. Bone health in patients with hematopoietic disorders of bone marrow origin: Systematic review and meta- analysis. J. Bone Miner. Res. 32, 731\u2013742 (2017).","journal-title":"J. Bone Miner. Res."},{"key":"94942_CR5","first-page":"M99","volume":"1471","author":"CR Parish","year":"2001","unstructured":"Parish, C. R., Freeman, C. & Hulett, M. D. Heparanase: A key enzyme involved in cell invasion. Biochim. Biophys. Acta 1471, M99-108 (2001).","journal-title":"Biochim. Biophys. Acta"},{"key":"94942_CR6","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1172\/JCI13662","volume":"108","author":"I Vlodavsky","year":"2001","unstructured":"Vlodavsky, I. & Friedmann, Y. Molecular properties and involvement of heparanase in cancer metastasis and angiogenesis. J. Clin. Invest. 108, 341\u2013347 (2001).","journal-title":"J. Clin. Invest."},{"key":"94942_CR7","doi-asserted-by":"publisher","first-page":"2443","DOI":"10.1111\/j.1538-7836.2006.02212.x","volume":"4","author":"Y Nadir","year":"2006","unstructured":"Nadir, Y. et al. Heparanase induces tissue factor expression in vascular endothelial and cancer cells. J. Thromb. Haemost. 4, 2443\u20132451 (2006).","journal-title":"J. Thromb. Haemost."},{"key":"94942_CR8","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1055\/s-0037-1608919","volume":"99","author":"Y Nadir","year":"2008","unstructured":"Nadir, Y. et al. Heparanase induces tissue factor pathway inhibitor expression and extracellular accumulation in endothelial and tumor cells. Thromb. Haemost. 99, 133\u2013141 (2008).","journal-title":"Thromb. Haemost."},{"key":"94942_CR9","doi-asserted-by":"publisher","first-page":"1927","DOI":"10.3324\/haematol.2010.023713","volume":"95","author":"Y Nadir","year":"2010","unstructured":"Nadir, Y. et al. Heparanase enhances the generation of activated factor X in the presence of tissue factor and activated factor VII. Haematologica 95, 1927\u20131934 (2010).","journal-title":"Haematologica"},{"key":"94942_CR10","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1160\/TH13-12-1049","volume":"112","author":"E Axelman","year":"2014","unstructured":"Axelman, E. et al. Novel peptides that inhibit heparanase activation of the coagulation system. Thromb. Haemost 112, 466\u2013477 (2014).","journal-title":"Thromb. Haemost"},{"key":"94942_CR11","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1111\/jth.13707","volume":"15","author":"Y Crispel","year":"2017","unstructured":"Crispel, Y. et al. Involvement of the heparanase procoagulant domain in bleeding and wound healing. J. Thromb. Haemost. 15, 1463\u20131472 (2017).","journal-title":"J. Thromb. Haemost."},{"key":"94942_CR12","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1160\/TH16-02-0119","volume":"116","author":"Y Crispel","year":"2016","unstructured":"Crispel, Y. et al. Peptides inhibiting heparanase procoagulant activity significantly reduce tumour growth and vascularisation in a mouse model. Thromb. Haemost. 116, 669\u2013678 (2016).","journal-title":"Thromb. Haemost."},{"key":"94942_CR13","doi-asserted-by":"publisher","first-page":"1654","DOI":"10.1016\/j.ajpath.2019.04.019","volume":"189","author":"N Nevo","year":"2019","unstructured":"Nevo, N. et al. Heparanase level in the microcirculation as a possible modulator of the metastatic process. Am. J. Pathol. 189, 1654\u20131663 (2019).","journal-title":"Am. J. Pathol."},{"key":"94942_CR14","doi-asserted-by":"publisher","first-page":"2249","DOI":"10.1242\/jcs.01068","volume":"117","author":"A Zetser","year":"2004","unstructured":"Zetser, A. et al. Processing and activation of latent heparanase occurs in lysosomes. J. Cell Sci. 117, 2249\u20132258 (2004).","journal-title":"J. Cell Sci."},{"key":"94942_CR15","doi-asserted-by":"publisher","first-page":"102179","DOI":"10.1016\/j.rpth.2023.102179","volume":"7","author":"S Ghanem","year":"2023","unstructured":"Ghanem, S., Keren-Politansky, A., Kaplan, V., Crispel, Y. & Nadir, Y. Tissue factor-heparanase complex: Intracellular nonhemostatic effects. Res. Pract. Thromb. Haemost. 7, 102179 (2023).","journal-title":"Res. Pract. Thromb. Haemost."},{"key":"94942_CR16","doi-asserted-by":"publisher","first-page":"e3","DOI":"10.1016\/j.thromres.2011.03.008","volume":"128","author":"Y Nadir","year":"2011","unstructured":"Nadir, Y., Kenig, Y., Drugan, A., Shafat, I. & Brenner, B. An assay to evaluate heparanase procoagulant activity. Thromb Res. 128, e3-8 (2011).","journal-title":"Thromb Res."},{"key":"94942_CR17","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1016\/j.bbrc.2006.01.048","volume":"341","author":"I Shafat","year":"2006","unstructured":"Shafat, I. et al. An ELISA method for the detection and quantification of human heparanase. Biochem. Biophys. Res. Commun. 341, 958\u2013963 (2006).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"94942_CR18","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.bone.2013.07.024","volume":"57","author":"J Ruan","year":"2013","unstructured":"Ruan, J. et al. Heparanase inhibits osteoblastogenesis and shifts bone marrow progenitor cell fate in myeloma bone disease. Bone 57, 10\u201317 (2013).","journal-title":"Bone"},{"key":"94942_CR19","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1002\/jcp.20625","volume":"207","author":"V Kram","year":"2006","unstructured":"Kram, V. et al. Heparanase is expressed in osteoblastic cells and stimulates bone formation and bone mass. J. Cell Physiol. 207, 784\u2013792 (2006).","journal-title":"J. Cell Physiol."},{"key":"94942_CR20","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1097\/JCMA.0000000000000391","volume":"83","author":"JY Wang","year":"2020","unstructured":"Wang, J. Y. & Chen, C. F. Heparanase-1 facilitates bone remodeling on bone defect animal model with optimal dosage and treatment duration. J. Chin. Med. Assoc. 83, 799\u2013800 (2020).","journal-title":"J. Chin. Med. Assoc."},{"key":"94942_CR21","doi-asserted-by":"publisher","first-page":"28010","DOI":"10.1074\/jbc.M110.116384","volume":"285","author":"F Levy-Adam","year":"2010","unstructured":"Levy-Adam, F. et al. Heparanase 2 interacts with heparan sulfate with high affinity and inhibits heparanase activity. J. Biol. Chem. 285, 28010\u201328019 (2010).","journal-title":"J. Biol. Chem."},{"key":"94942_CR22","doi-asserted-by":"publisher","first-page":"44084","DOI":"10.1074\/jbc.M402131200","volume":"279","author":"S Gingis-Velitski","year":"2004","unstructured":"Gingis-Velitski, S. et al. Heparanase uptake is mediated by cell membrane heparan sulfate proteoglycans. J. Biol. Chem. 279, 44084\u201344092 (2004).","journal-title":"J. Biol. Chem."},{"key":"94942_CR23","doi-asserted-by":"publisher","first-page":"S221","DOI":"10.1097\/01.CCM.0000057847.32590.C1","volume":"31","author":"WC Aird","year":"2003","unstructured":"Aird, W. C. Endothelial cell heterogeneity. Crit. Care Med. 31, S221\u2013S230 (2003).","journal-title":"Crit. Care Med."},{"key":"94942_CR24","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1161\/01.RES.0000255690.03436.ae","volume":"100","author":"WC Aird","year":"2007","unstructured":"Aird, W. C. Phenotypic heterogeneity of the endothelium: II. Representative vascular beds. Circ. Res. 100, 174\u2013190 (2007).","journal-title":"Circ. Res."},{"key":"94942_CR25","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1161\/01.RES.0000255691.76142.4a","volume":"100","author":"WC Aird","year":"2007","unstructured":"Aird, W. C. Phenotypic heterogeneity of the endothelium: I. Structure, function, and mechanisms. Circ. Res. 100, 158\u2013173 (2007).","journal-title":"Circ. Res."},{"key":"94942_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.atherosclerosis.2019.01.002","volume":"282","author":"A Mojiri","year":"2019","unstructured":"Mojiri, A. et al. Endothelial cells of different organs exhibit heterogeneity in von Willebrand factor expression in response to hypoxia. Atherosclerosis 282, 1\u201310 (2019).","journal-title":"Atherosclerosis"},{"key":"94942_CR27","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1093\/rheumatology\/kep044","volume":"48","author":"D Morimoto","year":"2009","unstructured":"Morimoto, D. et al. Equivalent osteoblastic differentiation function of human mesenchymal stem cells from rheumatoid arthritis in comparison with osteoarthritis. Rheumatology (Oxford) 48, 643\u2013649 (2009).","journal-title":"Rheumatology (Oxford)"},{"key":"94942_CR28","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1186\/scrt328","volume":"4","author":"F Langenbach","year":"2013","unstructured":"Langenbach, F. & Handschel, J. Effects of dexamethasone, ascorbic acid and beta-glycerophosphate on the osteogenic differentiation of stem cells in vitro. Stem Cell Res. Ther. 4, 117 (2013).","journal-title":"Stem Cell Res. Ther."},{"key":"94942_CR29","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1080\/03008207.2021.1894140","volume":"63","author":"L Lopez-Delgado","year":"2022","unstructured":"Lopez-Delgado, L. et al. Osteogenic capacity of mesenchymal stem cells from patients with osteoporotic hip fractures in vivo. Connect Tissue Res. 63, 243\u2013255 (2022).","journal-title":"Connect Tissue Res."},{"key":"94942_CR30","doi-asserted-by":"publisher","first-page":"e444","DOI":"10.1016\/j.thromres.2010.09.007","volume":"126","author":"Y Nadir","year":"2010","unstructured":"Nadir, Y., Kenig, Y., Drugan, A., Zcharia, E. & Brenner, B. Involvement of heparanase in vaginal and cesarean section deliveries. Thromb Res. 126, e444\u2013e450 (2010).","journal-title":"Thromb Res."},{"key":"94942_CR31","doi-asserted-by":"publisher","first-page":"e251","DOI":"10.1016\/j.thromres.2009.11.026","volume":"125","author":"Y Nadir","year":"2010","unstructured":"Nadir, Y. et al. Involvement of Heparanase in early pregnancy losses. Thromb Res. 125, e251\u2013e257 (2010).","journal-title":"Thromb Res."},{"key":"94942_CR32","doi-asserted-by":"publisher","first-page":"2372","DOI":"10.1093\/humrep\/det257","volume":"28","author":"M Matan","year":"2013","unstructured":"Matan, M., Axelman, E., Brenner, B. & Nadir, Y. Heparanase procoagulant activity is elevated in women using oral contraceptives. Hum. Reprod. 28, 2372\u20132380 (2013).","journal-title":"Hum. Reprod."},{"key":"94942_CR33","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1160\/TH15-04-0320","volume":"115","author":"I Kogan","year":"2016","unstructured":"Kogan, I. et al. JAK-2 V617F mutation increases heparanase procoagulant activity. Thromb Haemost. 115, 73\u201380 (2016).","journal-title":"Thromb Haemost."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-94942-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-94942-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-94942-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,23]],"date-time":"2025-06-23T13:54:38Z","timestamp":1750686878000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-94942-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,21]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["94942"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-94942-x","relation":{},"ISSN":["2045-2322"],"issn-type":[{"type":"electronic","value":"2045-2322"}],"subject":[],"published":{"date-parts":[[2025,4,21]]},"assertion":[{"value":"26 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"13713"}}